2-(4-((1,2-DIMETHYLBENZIMIDAZOL-5-YL)SULFONYL-METHYLAMINO)PHENYL)-6-((2-FLUORO-4-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)CYCLOHEXANE-1-CARBOXYLIC ACID, (1R,2S,6R)-
UNII S38AE44HWC
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-(4-((1,2-dimethylbenzimidazol-5-yl)sulfonyl-methylamino)phenyl)-6-((2-fluoro-4-(trifluoromethyl)phenyl)carbamoyl)cyclohexane-1-carboxylic Acid, (1r,2s,6r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S38AE44HWC.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3064599-36-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H30F4N4O5S CPNRNECAIBPHJF-MVOZIGHISA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-(4-((1,2-dimethylbenzimidazol-5-yl)sulfonyl-methylamino)phenyl)-6-((2-fluoro-4-(trifluoromethyl)phenyl)carbamoyl)cyclohexane-1-carboxylic Acid, (1r,2s,6r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.